Mogens Groenvold

@mold01

Professor in Palliative Care and Quality of Life Research, University of Copenhagen and Bispebjerg Hospital, Denmark

Copenhagen, Denmark
Vrijeme pridruživanja: srpanj 2010.

Tweetovi

Blokirali ste korisnika/cu @mold01

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mold01

  1. proslijedio/la je Tweet
    31. sij

    publishes its new standards for and analysis in cancer. Paper is accompanied by an interactive webtool to align PRO objectives with the statistical method used .

    Poništi
  2. 31. sij
    Poništi
  3. proslijedio/la je Tweet
    28. sij

    Very interesting report on UK health research funding. The proportion of funding allocated to end of life care research is 0.21% total research spend, with around half funded by .

    Poništi
  4. 13. pro 2019.

    A great honour to take part in the Farewell Symposium for Professor Neil Aaronson, celebrating his monumental contribution to the fields of patient-reported outcomes (PRO) research and psychosocial oncology. -C30

    Poništi
  5. proslijedio/la je Tweet
    Poništi
  6. proslijedio/la je Tweet
    3. pro 2019.

    A systematic review by demonstrates the prognostic value of certain parameters. assessments can play a key role in and , enabling treatments and demonstrating to .

    Poništi
  7. proslijedio/la je Tweet

    . researchers evaluate the usefulness of -reported outcomes as prognostic factors for . Click to read more:

    Poništi
  8. proslijedio/la je Tweet
    29. stu 2019.

    Sorry SUV drivers, we have bad news. SUVs are the second-biggest cause of the rise in global carbon dioxide emissions during the past decade. Only the power sector is a bigger contributor.

    Poništi
  9. 26. stu 2019.

    Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    26. stu 2019.
    Prikaži ovu nit
    Poništi
  11. 26. stu 2019.
    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    22. lis 2019.

    Pre-testing of survivorship questionnaire -SURV111 across 17 countries among cancer survivors demonstrated good psychometric properties. -SURV111 will be available soon.

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    22. lis 2019.

    EORTC CAT Core short forms (SFs) allows implementation of the EORTC CAT using paper&pen. SFs are directly comparable to EORTC CAT Core and the QLQ-C30 and may be used interchangeably.

    Poništi
  14. proslijedio/la je Tweet
    22. lis 2019.

    EORTC QLQ-F17 is now available, enabling users to measure functioning scales from the QLQ-C30 with other EORTC modules, item lists and other measurement systems.

    Poništi
  15. 22. lis 2019.

    Dr Jammbe Musoro presents MID estimates at

    Poništi
  16. proslijedio/la je Tweet
    22. lis 2019.

    Claire Piccinin, QOL Researcher, will talk about “Seeking a Mutual Understanding of Health-Related Quality of Life Domains: Mapping the EORTC QLQ-C30 onto the WHO-ICF” Interested? Meet her @ 3:35 PM (GMT-7) 🎬

    Poništi
  17. proslijedio/la je Tweet
    22. lis 2019.

    Prof Mogens Groenvold: Respect patients choice for care planning in advanced cancer

    Poništi
  18. proslijedio/la je Tweet
    18. lis 2019.

    , Head of the QOL dpt stated “it’s the second year in a row that the EORTC has had 12 abstracts presented at , which demonstrates a consistent and high quality output of international standard.”

    Poništi
  19. proslijedio/la je Tweet
    27. ruj 2019.

    It’s been a hugely successful 2 day meeting, with over 140 PRO researchers and clinicians developing new measures and designing trials to better assess the next generation of cancer treatments! Well done to a hard working group...

    Poništi
  20. 10. ruj 2019.

    Congratulations to Maiken Bang Hansen for succesfully defending her PhD thesis at Bispebjerg and Frederiksberg Hospital. This was the second thesis based on Danish Palliative Care Database.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·